Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 4, 2006 - Issue 3
Submit an article Journal homepage
65
Views
16
CrossRef citations to date
0
Altmetric
Review

Current and future developments in travelers’ diarrhea therapy

Hoonmo L Koo Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
&
Herbert L DuPont St Luke’s Episcopal Health System, 6720 Bertner Avenue, MC 164, Houston, TX 77030, USA. [email protected]
Pages 417-427 | Published online: 10 Jan 2014

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Luigi Santacroce, Ioannis Alexandros Charitos & Lucrezia Bottalico. (2019) A successful history: probiotics and their potential as antimicrobials. Expert Review of Anti-infective Therapy 17:8, pages 635-645.
Read now
Mark Pimentel. (2009) Review of rifaximin as treatment for SIBO and IBS. Expert Opinion on Investigational Drugs 18:3, pages 349-358.
Read now
E.A. Debbia, E. Maioli, S. Roveta & A. Marchese. (2008) Effects of Rifaximin on Bacterial Virulence Mechanisms at Supra- and Sub-Inhibitory Concentrations. Journal of Chemotherapy 20:2, pages 186-194.
Read now

Articles from other publishers (13)

Lynne V. McFarland & Shan Goh. (2019) Are probiotics and prebiotics effective in the prevention of travellers’ diarrhea: A systematic review and meta-analysis. Travel Medicine and Infectious Disease 27, pages 11-19.
Crossref
Guy W. Neff, Michael Jones, Mark Jonas, Ravi Ravinuthala, David Novick, Tiffany E. Kaiser & Nyingi Kemmer. (2013) Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy. Journal of Clinical Gastroenterology 47:2, pages 188-192.
Crossref
Sanjin Alajbegovic, John W Sanders, Deborah E Atherly & Mark S Riddle. (2012) Effectiveness of rifaximin and fluoroquinolones in preventing travelers’ diarrhea (TD): a systematic review and meta-analysis. Systematic Reviews 1:1.
Crossref
Magdalena E. Kendall, Stacy Crim, Kathleen Fullerton, Pauline V. Han, Alicia B. Cronquist, Beletshachew Shiferaw, L. Amanda Ingram, Joshua Rounds, Eric D. Mintz & Barbara E. Mahon. (2012) Travel-Associated Enteric Infections Diagnosed After Return to the United States, Foodborne Diseases Active Surveillance Network (FoodNet), 2004–2009. Clinical Infectious Diseases 54:suppl_5, pages S480-S487.
Crossref
Guy W. Neff, Michael Jones, Taylor Broda, Mark Jonas, Ravinuthala Ravi, David Novick, Tiffany E. Kaiser & Nyingi Kemmer. (2012) Durability of Rifaximin Response in Hepatic Encephalopathy. Journal of Clinical Gastroenterology 46:2, pages 168-171.
Crossref
David T. Rubin, Sunana Sohi, Matthew Glathar, Tojo Thomas, Nicole Yadron & Bonnie L. Surma. (2011) Rifaximin Is Effective for the Treatment of Clostridium difficile —Associated Diarrhea: Results of an Open-Label Pilot Study . Gastroenterology Research and Practice 2011, pages 1-5.
Crossref
P.S. Mantry & S. Munsaf. (2010) Rifaximin for the Treatment of Hepatic Encephalopathy. Transplantation Proceedings 42:10, pages 4543-4547.
Crossref
Lewis W. Teperman & Vincent P. Peyregne. (2010) Considerations on the Impact of Hepatic Encephalopathy Treatments in the Pretransplant Setting. Transplantation 89:7, pages 771-778.
Crossref
Francisco Martinez‐Sandoval, Charles D. Ericsson, Zhi‐Dong Jiang, Pablo C. Okhuysen, Juan H.M. Meléndez Romero, Norma Hernandez, William P. Forbes, Audrey Shaw, Enoch Bortey & Herbert L. DuPont. (2010) Prevention of Travelers' Diarrhea With Rifaximin in US Travelers to Mexico. Journal of Travel Medicine 17:2, pages 111-117.
Crossref
Charles D. Ericsson, Nicolas A. Melgarejo, Tomas Jelinek & Anne McCarthy. (2009) Travelers’ Preferences for the Treatment and Prevention of Acute Diarrhea. Journal of Travel Medicine 16:3, pages 172-178.
Crossref
Bo Shen, Feza H Remzi, A Rocio Lopez & Elaine Queener. (2008) Rifaximin for maintenance therapy in antibiotic-dependent pouchitis. BMC Gastroenterology 8:1.
Crossref
H. Scott Hurd & Sasidhar Malladi. (2008) A Stochastic Assessment of the Public Health Risks of the Use of Macrolide Antibiotics in Food Animals. Risk Analysis 28:3, pages 695-710.
Crossref
David W. Hecht, Minerva A. Galang, Susan P. Sambol, James R. Osmolski, Stuart Johnson & Dale N. Gerding. (2007) In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004 . Antimicrobial Agents and Chemotherapy 51:8, pages 2716-2719.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.